Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain

Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) and Biofourmis, a global leader in technology-enabled care delivery, announced that they have entered into a new partnership agreement for the continued development and real-world use of digital solutions to objectively measure pain in patients with endometriosis ...

Related Keywords

Tokyo ,Japan ,Boston ,Massachusetts ,United States ,India ,Singapore ,Biofourmi Biovitals ,Kuldeep Singh Rajput ,Osamu Okuda ,Chugai Pharmaceutical Co Ltd ,Market Of The Tokyo Stock Exchange ,Youtube ,Linkedin ,American College Of Obstetricians ,Twitter ,Roche Group ,Insight Business ,Biofourmis Partner ,Objective Assessment ,Pain Using Digital Technology ,Press Release ,Prime Market ,Tokyo Stock ,Accessed February ,